Chemical biology: development of novel molecular probes for DNA sequencing analysis and disease gene discovery Medicinal chemistry: development of new imaging and therapeutic agents towards cancer and ...
U.S. pharmaceutical company Eli Lilly plans to disclose the topline results of its phase 3 clinical trial for ‘remternuzumab,’ a new drug candidate developed as a successor to its Alzheimer’s ...